Chlorine in PDB 7nr8: Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2

Enzymatic activity of Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2

All present enzymatic activity of Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2:
2.7.11.24;

Protein crystallography data

The structure of Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2, PDB code: 7nr8 was solved by M.O'reilly, A.Cleasby, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 56.71 / 1.63
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 48.97, 70.872, 60.461, 90, 110.28, 90
R / Rfree (%) 17.1 / 21.4

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2 (pdb code 7nr8). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2, PDB code: 7nr8:

Chlorine binding site 1 out of 1 in 7nr8

Go back to Chlorine Binding Sites List in 7nr8
Chlorine binding site 1 out of 1 in the Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl408

b:23.6
occ:0.86
CL1 A:UOE408 0.0 23.6 0.9
C25 A:UOE408 1.7 20.9 0.9
C24 A:UOE408 2.7 20.0 0.9
H56 A:UOE408 2.7 20.1 0.9
C13 A:UOE408 2.7 19.9 0.9
H67 A:UOE408 2.8 20.0 0.9
OE1 A:GLN105 3.1 22.1 1.0
C9 A:UOE408 3.1 20.1 0.9
C8 A:UOE408 3.2 20.3 0.9
O A:HOH723 3.5 43.9 1.0
CD A:GLN105 3.6 22.5 1.0
CB A:GLN105 3.7 22.6 1.0
N23 A:UOE408 3.9 19.9 0.9
N14 A:UOE408 4.0 20.6 0.9
CD1 A:LEU156 4.0 22.6 1.0
CG A:GLN105 4.1 20.7 1.0
CB A:ALA52 4.3 28.4 1.0
CG1 A:ILE84 4.3 20.0 1.0
C10 A:UOE408 4.3 20.6 0.9
NE2 A:GLN105 4.3 23.6 1.0
C15 A:UOE408 4.4 20.5 0.9
C7 A:UOE408 4.4 20.9 0.9
O A:ASP106 4.4 26.6 1.0
CD1 A:ILE84 4.5 21.4 1.0
H55 A:UOE408 4.8 21.0 0.9
O A:HOH585 4.9 22.5 1.0
CA A:GLN105 5.0 25.0 1.0

Reference:

T.D.Heightman, V.Berdini, L.Bevan, I.M.Buck, M.G.Carr, A.Courtin, J.E.Coyle, J.E.H.Day, C.East, L.Fazal, C.M.Griffiths-Jones, S.Howard, J.Kucia-Tran, V.Martins, S.Muench, J.M.Munck, D.Norton, M.O'reilly, N.Palmer, P.Pathuri, T.M.Peakman, M.Reader, D.C.Rees, S.J.Rich, A.Shah, N.G.Wallis, H.Walton, N.E.Wilsher, A.J.Woolford, M.Cooke, D.Cousin, S.Onions, J.Shannon, J.Watts, C.W.Murray. Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2. J.Med.Chem. V. 64 12286 2021.
ISSN: ISSN 0022-2623
PubMed: 34387469
DOI: 10.1021/ACS.JMEDCHEM.1C00905
Page generated: Fri Nov 5 12:29:17 2021

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy